Francesca Paradiso

7PUBLICATIONS
114CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical mycologyMicroelectromechanical systems (MEMS)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 04, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Aug 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS G12D inhibition in pancreatic ductal adenocarcinoma.

Kathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li

|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Feb 23, 2023
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.

Gabriele Romano, Francesca Paradiso, Peng Li

|Mar 10, 2022
Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.

Francesca Paradiso, Stefania Lenna, S Andrea Gazze

Pageof 2

Frequent Collaborators

3 joint publications

Francesca Taraballi

3 joint publications

David S Hong

2 joint publications

Jordi Rodon

2 joint publications

Anirban Maitra